Sather Financial Group’s Pfizer PFE Stock Holding History

Sather Financial Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$244K	Buy	10,126 +181	+2%	+$4.74K	0.01%	105
2026 Q1	$279K	Sell	9,945 -653	-6%	-$17.4K	0.02%	86
2025 Q4	$264K	Sell	10,598 -160	-1%	-$4.04K	0.01%	93
2025 Q3	$274K	Buy	10,758 +963	+10%	+$23.8K	0.01%	88
2025 Q2	$237K	Hold	9,795	–	–	0.01%	101
2025 Q1	$248K	Hold	9,795	–	–	0.02%	85
2024 Q4	$260K	Hold	9,795	–	–	0.02%	79
2024 Q3	$283K	Hold	9,795	–	–	0.02%	79
2024 Q2	$274K	Sell	9,795 -4,100	-30%	-$113K	0.02%	73
2024 Q1	$386K	Hold	13,895	–	–	0.03%	66
2023 Q4	$400K	Hold	13,895	–	–	0.03%	60
2023 Q3	$461K	Hold	13,895	–	–	0.04%	60
2023 Q2	$510K	Hold	13,895	–	–	0.04%	63
2023 Q1	$567K	Hold	13,895	–	–	0.05%	61
2022 Q4	$712K	Hold	13,895	–	–	0.06%	67
2022 Q3	$608K	Hold	13,895	–	–	0.07%	47
2022 Q2	$729K	Hold	13,895	–	–	0.08%	43
2022 Q1	$719K	Buy	+13,895	New	+$721K	0.06%	50

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sather Financial Group's PFE Position: Q2 2026 in Review

Sather Financial Group increased its Pfizer (PFE) stake by 1.8% in Q2 2026, buying an estimated $4.74K and bringing the position to 10,126 shares worth $244K. The position accounts for 0.01% of the portfolio, ranked #105.

Sather Financial Group first reported a position in PFE in Q1 2022 and has held it in 18 quarters since. The position peaked at $729K in Q2 2022. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Sather Financial Group held 10,126 shares of Pfizer worth $244K as of Q2 2026.
Sather Financial Group bought 181 Pfizer shares in Q2 2026, an estimated $4.74K.
Pfizer made up 0.01% of Sather Financial Group's portfolio in Q2 2026, its #105 holding.
Sather Financial Group first reported a position in Pfizer in Q1 2022 and has held it in 18 quarters since.
Sather Financial Group's Pfizer position peaked at $729K in Q2 2022.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sather Financial Group's 13F filing for Q2 2026, filed 30 Jul 2026.